de Tullio P - Search Results

1

Modulation of mitochondrial respiration rate and calcium-induced swelling by new cromakalim analogues.

Mouithys-Mickalad A, Ceusters J, Charif M, El Moualij B, Schoumacher M, Plyte S, Franck T, Bettendorff L, Pirotte B, Serteyn D, de Tullio P. Mouithys-Mickalad A, et al. Among authors: de tullio p. Chem Biol Interact. 2020 Nov 1;331:109272. doi: 10.1016/j.cbi.2020.109272. Epub 2020 Sep 30. Chem Biol Interact. 2020. PMID: 33010220

2

[Potassium channel activators: comparative structural study of pinacidil, diazoxide and cromakalim].

Dupont L, Pirotte B, de Tullio P, Masereel B, Delarge J. Dupont L, et al. Among authors: de tullio p. Ann Pharm Fr. 1995;53(5):201-8. Ann Pharm Fr. 1995. PMID: 7503508 French.

3

A pyridothiadiazine (BPDZ 44) as a new and potent activator of ATP-sensitive K+ channels.

Pirotte B, Antoine MH, de Tullio P, Hermann M, Herchuelz A, Delarge J, Lebrun P. Pirotte B, et al. Among authors: de tullio p. Biochem Pharmacol. 1994 Apr 20;47(8):1381-6. doi: 10.1016/0006-2952(94)90337-9. Biochem Pharmacol. 1994. PMID: 8185645

4

3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers?

Pirotte B, de Tullio P, Lebrun P, Antoine MH, Fontaine J, Masereel B, Schynts M, Dupont L, Herchuelz A, Delarge J. Pirotte B, et al. Among authors: de tullio p. J Med Chem. 1993 Oct 15;36(21):3211-3. doi: 10.1021/jm00073a025. J Med Chem. 1993. PMID: 8230110 No abstract available.

5

Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62.

Lebrun P, Antoine MH, Ouedraogo R, Kane C, Dunne M, Hermann M, Herchuelz A, Masereel B, Delarge J, de Tullio P, Pirotte B. Lebrun P, et al. Among authors: de tullio p. J Pharmacol Exp Ther. 1996 Apr;277(1):156-62. J Pharmacol Exp Ther. 1996. PMID: 8613913

6

Synthesis and biological evaluation of new 3-aralkylamino-2-aryl-2H-1, 2,4-pyridothiadiazine 1,1-dioxides as potential CCK-receptor ligands.

De Tullio P, Pirotte B, Neven P, Masereel B, Dewalque D, Diouf O, Podona T, Caignard D, Renard P, Delarge J. De Tullio P, et al. J Pharm Pharmacol. 1997 May;49(5):463-71. doi: 10.1111/j.2042-7158.1997.tb06825.x. J Pharm Pharmacol. 1997. PMID: 9178178

7

Effect of potassium channel openers on the firing rate of hippocampal pyramidal cells and A10 dopaminergic neurons in vitro.

Scuvée-Moreau J, Seutin V, Vrijens B, Pirotte B, De Tullio P, Massotte L, Albert A, Delarge J, Dresse A. Scuvée-Moreau J, et al. Among authors: de tullio p. Arch Physiol Biochem. 1997 Sep;105(5):421-8. doi: 10.1076/apab.105.5.421.3285. Arch Physiol Biochem. 1997. PMID: 9439778

8

Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).

de Tullio P, Delarge J, Pirotte B. de Tullio P, et al. Curr Med Chem. 1999 Jun;6(6):433-55. Curr Med Chem. 1999. PMID: 10213792 Review.

9

3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluation.

Pirotte B, Ouedraogo R, de Tullio P, Khelili S, Somers F, Boverie S, Dupont L, Fontaine J, Damas J, Lebrun P. Pirotte B, et al. Among authors: de tullio p. J Med Chem. 2000 Apr 20;43(8):1456-66. doi: 10.1021/jm991069o. J Med Chem. 2000. PMID: 10780901

10

Therapeutic and chemical developments of cholecystokinin receptor ligands.

de Tullio P, Delarge J, Pirotte B. de Tullio P, et al. Expert Opin Investig Drugs. 2000 Jan;9(1):129-46. doi: 10.1517/13543784.9.1.129. Expert Opin Investig Drugs. 2000. PMID: 11060666 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page